“Should We Phenobarb-it-All?” A Phenobarbital-Based Protocol for Non-Intensive Care Unit Trauma Patients at High Risk of or Experiencing Alcohol Withdrawal
The American Surgeon™ · 2024
DOI: 10.1177/00031348241244639 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift The American Surgeon™, 2024. Verfasst von Michelle Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA. Hauptthemen laut MEDLINE: Phenobarbital, Benzodiazepines, Clinical Protocols. Die Arbeit nennt 23 Literaturangaben.
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Alcohol use is frequent in trauma patients and alcohol withdrawal syndrome (AWS) is associated with significant morbidity. Benzodiazepines are commonly used for AWS, but may cause neurologic and respiratory adverse events (AEs). The objective was to evaluate the effectiveness and safety of a phenobarbital-based protocol for the treatment of AWS in non-intensive care unit (ICU) trauma patients.
Methods
Adult non-ICU trauma patients at high risk of or experiencing AWS PRE and POST implementation of a phenobarbital-based protocol were included. Outcomes were AWS-related complications (AWS-RC), benzodiazepine use, adjunctive medication use, hospital length of stay (HLOS), and medication-related AEs. Subgroup analyses were performed on patients with traumatic brain injury (TBI), rib fractures, and at high risk of severe AWS.
Results
Overall, 110 patients were included (51 PRE, 59 POST). AWS-RC developed in 17 PRE patients compared to 10 POST patients (33% vs 17%; P = .05). PRE patients were more likely to receive benzodiazepines (88% vs 42%, P < .0001) and higher total dose (11 vs 4 mg lorazepam equivalent; P = .001). No difference noted in HLOS (8 vs 8 days, P = .27), adjunctive medication use (49% vs 54%, P = .60), or AEs (57% vs 39%, P = .06). There was no difference in AWS-RC in the TBI subgroup ( P = .19), less AEs in the rib fracture POST subgroup ( P = .04), and less AWS-RC in the high risk of severe AWS POST subgroup ( P = .03).
Discussion
A phenobarbital-based protocol in trauma patients is effective in preventing AWS-RC and decreasing benzodiazepine use without increasing AEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Department of Surgery, Maine Medical Center, Portland, ME, USA.
- Department of Pharmacy, Maine Medical Center, Portland, ME, USA.
- Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
ORCID-Profile: Kathryn E Smith
Zitieren
APA
Wang, M., Falank, C., Simboli, V., Ontengco, J. B., Spurling, B., Rappold, J., Chung, B., & Smith, K. E. (2024). “Should We Phenobarb-it-All?” A Phenobarbital-Based Protocol for Non-Intensive Care Unit Trauma Patients at High Risk of or Experiencing Alcohol Withdrawal. The American Surgeon™. https://doi.org/10.1177/00031348241244639
Vancouver
Wang M, Falank C, Simboli V, Ontengco JB, Spurling B, Rappold J, et al. “Should We Phenobarb-it-All?” A Phenobarbital-Based Protocol for Non-Intensive Care Unit Trauma Patients at High Risk of or Experiencing Alcohol Withdrawal. The American Surgeon™. 2024. doi:10.1177/00031348241244639
BibTeX
@article{Wang2024,
author = {Wang, Michelle and Falank, Carolyne and Simboli, Vincent and Ontengco, Julianne B and Spurling, Brandi and Rappold, Joseph and Chung, Bruce and Smith, Kathryn E},
title = {“Should We Phenobarb-it-All?” A Phenobarbital-Based Protocol for Non-Intensive Care Unit Trauma Patients at High Risk of or Experiencing Alcohol Withdrawal},
journal = {The American Surgeon™},
year = {2024},
doi = {10.1177/00031348241244639}
}
EUVIMED